To woo more customers, try a ‘domain mindset’
By
Firms that shift to a “domain mindset” can help fill customers’ needs while expanding their own business opportunities.
By
Firms that shift to a “domain mindset” can help fill customers’ needs while expanding their own business opportunities.
By
Firms that embrace digital innovation can see value from operations, customers, and becoming a go-to destination in an ecosystem. Kaiser Permanente is one standout.
By
The studies describe new methods for accelerating drug approvals during pandemics and for providing more accurate measures of the probabilities of success for clinical trials of vaccines.
By
Cybersecurity remains a priority in the pandemic. Here’s how experts from top firms are tackling COVID-19 scams, phishing, and more.
By
What are the sources of resilience and renewal in America’s small towns and rural areas?
By
MIT study explores the key factors behind patient outcomes in clinical trials evaluating new treatments for non-small-cell lung cancer.
By
MIT Sloan and CSAIL researchers apply artificial intelligence techniques to one of the largest datasets of clinical trial outcomes to handicap the drug and device approval process
By
Companies whose board members are digitally savvy outperform other companies in areas like revenue growth, return on assets, and market cap growth.
By
USA Lab is available to MIT Sloan students and graduate students from across the broader MIT campus.
By
The MIT Laboratory for Financial Engineering (LFE) and Informa Pharma Intelligence announced a new initiative, Project ALPHA (Analytics for Life-sciences Professionals and Healthcare Advocates).